| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |